The success in profiling the phosphoproteome by mass spectrometry-based proteomics has been intimately related to the availability of methods that selectively enrich for phosphopeptides. To this end, we describe a protocol that combines two sequential enrichment steps. First, strong cation exchange (SCX) chromatography separates peptides by solution charge. Phosphate groups contribute to solution charge by adding a negative charge at pH 2.7. Therefore, at that pH, phosphopeptides are expected to elute earlier than their nonphosphorylated homologs. Second, immobilized metal affinity chromatography (IMAC) takes advantage of phosphate's affinity for metal ions such as Fe 3+ to uniformly enrich for phosphopeptides from the previously collected SCX fractions. We have successfully employed the SCX/IMAC enrichment strategy in the exploration of phosphoproteomes from several systems including mouse liver and Drosophila embryos characterizing over 5,500 and 13,000 phosphorylation events, respectively. The SCX/IMAC enrichment protocol requires 2 days, and the entire procedure from cells to a phosphorylation data set can be completed in less than 10 days.
INTRODUCTION
Reversible protein phosphorylation is a central regulatory mechanism of protein function in eukaryotes involved in countless cellular processes such as cell growth, cell differentiation, cell division and intercellular communication. Numerous efforts have been made aiming to understand how the phosphorylation state of a protein determines its conformation, activity and function, often on a single protein basis by mutation studies, kinase assays and 32 P radiolabeling techniques 1 . While the information obtained from such highly focused studies is invaluable, a single phosphorylation event is often just a single part of an intricate signaling network linking many proteins and multiple phosphorylation sites. Furthermore, protein phosphorylation is believed to be a ubiquitous modification targeting most cellular proteins in one particular cellular state or another. Therefore, it is of great importance to study protein phosphorylation on a large scale to obtain a global picture of signaling events within the cell. Much of this can now be accomplished through mass spectrometry (MS)-based proteomics 2 .
The main difficulty in large-scale phosphorylation studies is the limitation in detecting phosphorylated species directly from complex sample mixtures due to the generally low expression levels of many regulatory phosphoproteins. Furthermore, phosphorylation often occurs at low stoichiometry, where the phosphorylated form of the protein may account for less than 1% of the total protein 3 . To solve these dynamic range issues, it is essential to perform an enrichment step that specifically selects for phosphorylated species. In this regard, the ability to survey the phosphoproteome has been intimately associated with the development of phosphopeptideenrichment strategies.
Many enrichment strategies, normally performed at the peptide level, have proven successful. Peptide immunoprecipitation uses antibodies raised against a phosphorylation motif 4 to isolate a particular subset of the phosphoproteome. IMAC enrichment utilizes metal cations such as Fe 3+ (ref. 5) or Ga 3+ (ref. 6 ) to coordinate phosphate groups by affinity, whereas titanium 7, 8 and zirconium 9 oxides benefit from Lewis acid-base interactions.
Chemical approaches to modify the phosphoester have also been proposed, using b-elimination and Michael addition 10, 11 or phosphoramidite chemistry 12 . Finally, ion (cation or anion) exchange chromatography separates peptides on the basis of solution charge. For SCX chromatography, phosphopeptides at acidic pH (B2.7) retain an additional negative charge and can be generally separated from nonphosphorylated peptides due to their reduced retention in the stationary phase 13 .
Additionally, one can combine separation techniques with phosphopeptide enrichment to reduce sample complexity and increase coverage. We have previously used SDS-polyacrylamide gel electrophoresis (SDS-PAGE) on protein whole cell extract and combined it with either IMAC or TiO 2 at the level of peptides to identify around 2,000 and 3,000 phosphorylation sites from yeast Saccharomyces cerevisiae 14 and Schizosaccharomyces pombe 15 , respectively. However, the method that has proven most comprehensive in mapping the phosphoproteome is SCX chromatography combined with either IMAC [16] [17] [18] [19] or TiO 2 (refs. 20-22) , and this method is the subject of our protocol. As phosphopeptide enrichment by TiO 2 has been already described in detail in other protocols 23, 24 , we will be focusing this one on SCX/IMAC. Nevertheless any of the two IMAC or TiO 2 could be chosen in combination with SCX, and, in our hands, when working from the complexity obtained by collecting 10-15 fractions, both perform similarly. We believe superior results of SCX separation over gels are due to SCX chromatography grouping peptides on total charge and local charge distribution. Thus peptide mixtures to be enriched by IMAC or TiO 2 are more similar in acidic properties, and competition occurs between species that are more alike, not favoring any phosphopeptide (e.g., multiple phosphorylated peptides) in particular.
The SCX/IMAC approach has allowed us to identify more than 5,500 phosphorylation sites in mouse liver 18 and over 13,000 in fly embryos 19 with relatively little effort and in less than 24 h of MS analysis time. The requirements we had in mind when developing this workflow were simplicity, robustness and a reduction in the MS analysis time to manageable levels, with a future view of automation and increased throughput. The protocol described here maintains the general outline used in previous studies, with a few added improvements toward selectivity and throughput of the IMAC enrichment.
Experimental design
Although the protocol can be adapted to special needs and available resources, in our experience, the following points reflect the setup providing best results: (1) Starting with enough material: at least 5 mg of protein, recommended 15 mg. Limited success has been observed with sample amounts o2 mg in terms of total number of phosphopeptide identifications. (2) Gradient for SCX chromatography should be expanded in the low charge region, where most phosphopeptides are expected to elute. This produces similar phosphopeptide complexity in all fractions.
For tryptic digestions, this will be the +1/+2 region (see ANTICI-PATED RESULTS for further details), for LysC digestions, steeper gradients should be used to expand +2 and +3 regions. (3) Use relatively fresh IMAC resin (to be determined batch to batch) and do not freeze and thaw the resin multiple times. EQUIPMENT SETUP HPLC system for SCX chromatography Valco valve for manual injection set with a 500-ml loop, quaternary pump Agilent 1100 equipped with degasser, operating at 3 ml min À1 , photodiode array (PDA) detector from ThermoFisher set up to read at fixed 220-and 280-nm wavelengths. Semipreparative SCX column: polySULFOETHYL A, 9.4-mm inner diameter Â 200 mm length, 5-mm particle size, 200 Å pore size (PolyLC). LC-MS/MS equipment Famos autosampler (Dionex) with 10-ml loop and 2.4-ml injection needle, Agilent 1100 pumps operating between 80 and 300 ml min À1 and setup with a double-split system to provide an in-column flow rate of 0.5-1 ml min À1 on a microcapillary column 125 mm Â 18 cm column with hand-pulled tip packed with C 18 reverse-phase material (MagicC18AQ, MichromBioResources) and LTQOrbitrap mass spectrometer equipped with a nanospray source. The method used for acquisition consists of an 80-min method with 9-min loading time, 57-min gradient from 4% to 26% B (see REAGENT SETUP for solvent composition) and 60 min of MS data collection. For each scan cycle, one full MS scan acquired in the Orbitrap mass analyzer at 60,000 resolution, 1 Â 10 6 automatic gain control (AGC) target and 1,000 ms maximum ion accumulation time is followed by 10 MS/MS scans on the ten most intense ions in the linear ion trap (LTQ) at 3,000 signal threshold, 5,000 AGC target and 120 ms ' PAUSE POINT It is recommended to continue with Step 2 immediately to minimize protein degradation. If lysates need to be stored at this point, store them at À80 1C.
Protein reduction and alkylation 2| Add DTT from a 0.5 M stock to 5 mM final concentration and incubate for 25 min at 56 1C to reduce disulfide bonds. m CRITICAL STEP Avoid temperatures higher than 60 1C where urea-based carbamylation of lysines and protein N-termini can occur.
3| Allow the protein mixture to cool to room temperature and add iodoacetamide to 14 mM final concentration. Incubate for 30 min at room temperature and in the dark to alkylate cysteines. 8| Allow the digest to cool to room temperature and stop the digestion by acidification with TFA to 0.4% (vol/vol). Verify that the pH is o2.0; otherwise add more acid.
9| Centrifuge at 2,500g for 10 min at room temperature and discard the pellet.
Peptide desalting 10| Peptides must be desalted before SCX analysis to remove salts and urea from the digestion buffer. We use reverse-phase tC18 SepPak solid-phase extraction cartridges from Waters. The size of the cartridge should be selected on the basis of the amount of starting protein, considering their capacities are about 5% (wt/wt) of the packing material's weight. For example, for 20 mg of a protein digest, a SepPak with 500 mg of tC18 beads is recommended. In this protocol, we assume the use of 500 mg of SepPak (500-mg bulk material, 3 or 6 ml, 800-ml bed volume). Volumes should be adapted accordingly for different sizes.
A vacuum manifold can be used to increase solvent flow rates through the cartridge, or alternatively, air pressure is recommended for high-capacity SepPaks, as it provides more uniform peptide loading and elution.
11| Wash and condition the cartridge using 9 ml of ACN followed by 3 ml of 50% ACN and 0.5% HAcO.
12| Equilibrate with 9 ml of 0.1% TFA.
13| Load sample in 0.4% TFA.
14| Wash/desalt with 9 ml of 0.1% TFA.
15| Wash (to remove TFA) with 900 ml of 0.5% HAcO.
16| Elute with 5 ml of 50% ACN 0.5% HAcO and collect eluate in a 15-ml conical tube. See Box 1.
17| Freeze the eluate with liquid N 2 and lyophilize. The result here should be a white (sometimes yellowish) fluffy powder. ' PAUSE POINT At this point, samples can be stored at À20 1C for several weeks.
SCX chromatography 18|
Equilibrate the SCX HPLC system by running a blank run. Set up the gradient described in Table 1 for peptide separation.
19|
Resuspend lyophilized peptides in 400-500 ml of SCX buffer A and inject onto the HPLC system used for SCX chromatography. Collect twelve 4-min fractions from minute 1 to minute 49. m CRITICAL STEP For high-resolution chromatography, it is important to keep the amount of peptides loaded below the maximum column capacity. For the SCX column described here, the capacity is B16 mg of tryptic peptides, but best results are accomplished with B5 mg. Reproducible SCX chromatography is obtained with long and constant equilibration times.
20| Freeze the fractions with liquid N 2 and place them into the lyophilizer to eliminate the ACN. Fractions need not be completely dried for the next step; therefore, they can be used once the volume has been reduced by 30%.
Peptide desalting (II) 21| Peptides are again desalted to remove salts from the SCX buffers by reverse phase using solid-phase extraction cartridges as described above. We use 100 mg of tC18 SepPaks from Waters and a vacuum manifold. Wash and condition the cartridge with 3 ml of ACN and then with 3 ml of 50% ACN 0.5% HAcO.
22| Equilibrate with 3 ml of 0.1% TFA.
23| Load sample in 0.1% TFA.
24| Wash/desalt with 3 ml of 0.1% TFA. 26| Elute with 1 ml of 50% ACN 0.5% HAcO and collect the eluates in 2-ml Eppendorf tubes. See Box 1.
27| Freeze the eluates with liquid N 2 , and lyophilize or dry the peptides by vacuum centrifugation. ' PAUSE POINT At this point, sample can be stored at À20 1C for several weeks.
IMAC phosphopeptide enrichment 28| Prepare 100 ml of IMAC beads by washing them with 1 ml of IMAC binding buffer, turning over the vial a few times to resuspend all beads and spinning to remove the liquid. Repeat three times and prepare 50% slurry in the same buffer.
29| Prepare twelve 250-ml Eppendorf tubes and place 10 ml of IMAC beads slurry into each. Cutting the end of the tip facilitates pipetting of beads.
30| Dissolve each peptide fraction obtained from
Step 27 in 120 ml of IMAC-binding buffer and transfer to the IMAC beads obtained from Step 29.
31| Incubate peptides on beads for 60 min, with vigorous shaking, at room temperature.
32| During this time, prepare StageTips 26 by packing two disks of Empore 3M C18 material onto 250-ml pipette tips.
33| Wash and equilibrate StageTips by passing through sequentially 20 ml of MeOH, 20 ml of 50% ACN 0.5% HAcO and twice through 20 ml of 1% FA. For convenience and increased throughput, one can use a centrifuge by holding the StageTips within a 2-ml Eppendorf tube with the top part of a 500-ml Eppendorf body as an adaptor, limiting spinning speed to 2,000g and time to the minimum to get the liquid passed through. 35| Elute phosphopeptides from StageTips into vials for MS analysis with 40 ml of 50% ACN 0.5% HAcO.
36| Dry down the samples from Steps 34A(i) and 34B(i) (nonphosphorylated peptides) and Step 35 (phosphopeptides) by vacuum centrifugation. ' PAUSE POINT At this point, samples can be stored at À20 1C for several weeks.
LC-MS/MS analysis 37|
Resuspend samples in 10 ml of 5% ACN, 4% FA. For nonphosphopeptide samples, prepare a 1/100 dilution. Table 2 . Add an extra wash step with IMAC-binding buffer (i.e., repeat Step 34A(ii) or 34B(ii)) Very few total peptides were detected Starting amounts of protein were not sufficient
Although lower amounts might work, we recommend starting with at least 5 mg of protein IMAC resin is too old PhosSelect IMAC resin shelf life is less than 1 year. Store in small aliquots at À20 1C and do not freeze and thaw multiple times. When performance is decreased, replace it with a new batch (an SCX fraction prepared following this protocol can be used as a control)
There was a problem in the LC-MS/MS system Make sure LC-MS/MS system is working properly with a complex mixture standard (see EQUIPMENT SETUP)
ANTICIPATED RESULTS SCX/IMAC for the collection of large-scale phosphorylation data sets To exemplify the performance of the SCX/IMAC approach for large-scale phosphorylation studies, we applied this method to budding yeast S. cerevisiae. Figure 1a shows a schematic of the described workflow. Yeast were grown to mid-log phase, harvested and lysed. Fifteen milligrams of protein were reduced, alkylated and trypsin-digested. Desalted peptides were subjected to SCX chromatography and 12 fractions were collected, desalted, enriched by IMAC and desalted in one step (Fig. 1b) , and analyzed by LC-MS/MS on an LTQ Orbitrap. All MS/MS spectra collected were searched with the Sequest algorithm 27 against a composite yeast database with forward and reversed sequences 28 . Separation of peptides at pH 2.65 by SCX chromatography is shown in Figure 2 . The chromatogram of UV absorbance detection at 220 nm is displayed in Figure 2a , and the solution charge separation across the fractions of all the phosphopeptides detected after IMAC enrichment is shown in Figure 2b . The aforementioned buffer compositions and the gradient program we designed allow us to obtain increased separation between peptides with charges +1 and +2.
To show the phosphopeptide enrichment obtained in each step, the fraction of unique phosphopeptides over the total number of unique peptides identified within each fraction is plotted in Figure 3 . Figure 3a shows the result after SCX chromatography only, and Figure 3b shows the result after both SCX chromatography and IMAC. Although SCX chromatography alone provides some phosphopeptide enrichment in the three earliest fractions 13 , coupling SCX chromatography with IMAC increases phosphopeptide enrichment to 475% for most fractions.
We have observed that running technical duplicates (i.e., analyzing the same sample in the mass spectrometer twice) of complex peptide or phosphopeptide mixtures significantly increases the number of unique identifications 19, 25 , as the overlap between them is 70-75% (Fig. 4a) . On the other hand, the number of phosphopeptides identified repeatedly in two consecutive fractions represents only 20% of the total phosphopeptides from either of the two fractions compared, revealing good resolution from the SCX chromatography (Fig. 4b) .
Finally, discrimination between right and wrong answers using Sequest XCorr score filtering alone would set the threshold at a very high value if a 1% false-discovery identification rate (FDR) is desired, causing a significant number of right but low scoring answers to be thrown away ( Fig. 5a ; red, reverse/wrong answers; blue, forward minus reverse/right answers). Measuring accurate precursor masses and performing searches in a mass tolerance window B10 times bigger than the mass deviations measured (Fig. 5b) allows for an additional and powerful filtering criterion: mass error tolerance in a p.p.m. window 25, 29, 30 that rescues many low XCorr scoring answers, while maintaining an B1% FDR (Fig. 5c ).
Data analysis
When generating large data sets, special attention should be paid to estimating, minimizing and reporting error rates of peptide identifications, to minimize erroneous annotations in phosphorylation databases. To this end, we introduced the target-decoy database-searching strategy 28 , where searches are performed against a single database that contains all proteins from the organism of interest, first in the forward and then in the reverse direction, and an FDR is estimated on the basis of the number of hits derived from flagged reverse proteins. Importantly, reverse matches can be used to guide threshold selection for mass deviation, XCorr, solution charge state and dCn¢ parameters. Most laboratories performing large-scale phosphorylation studies have now adopted this simple and powerful approach for error rate determination 20, 31, 32 .
In addition to the issue of peptide false-discovery rates, analysis of phosphorylation (or other posttranslational modifications) by MS may introduce ambiguity associated with the precise position of the modification site. When more than one potential acceptor site exists in a peptide, some method of post-analysis verification should be used. The Ascore algorithm is a probability-based metric for assessing localization ambiguity 29 .
Besides these automated approaches for error-rate assessment and site localization, further validation for a subset of phosphopeptides might be desired, especially before follow-up biological experiments. Peptide synthesis constitutes the gold standard, where the MS/MS spectrum from the synthetic peptide is compared with the one acquired from the biological sample 33 . In addition, reanalysis of the sample using high-resolution MS/MS, different fragmentation techniques such as electron capture dissociation (ECD) 34 and electron transfer dissociation (ETD) 35 or fragmentation schemes such as neutral loss data-dependent MS 3 (ref. 13 ) and multistage activation 36 frequently bring additional confirmation for the phosphopeptide entity. Finally, computer-assisted manual inspection of MS/MS, looking for phosphopeptide diagnostic ions such as fragments derived from neutral loss of phosphoric acid, which often verify the presence of a phosphoserine or phosphothreonine in the sequence, and proline-driven fragmentation, has been regularly practiced 13, 16 with the drawback of being highly subjective, and correct discrimination is very much dependent on user expertise.
To perform database searches and data analysis, in our studies, RAW files were converted to the mzXML file format and imported into a MySQL relational database. MS/MS spectra were searched against a target-decoy 28 S. cerevisiae ORFs database using the Sequest algorithm (version 27, revision 12), with 50 p.p.m. precursor mass tolerance, tryptic enzyme specificity with two missed cleavages allowed and static modification of cysteines (+57.02146, carboxamidomethylation). Dynamic modifications were 79.96633 Da on Ser, Thr and Tyr (phosphorylation) and 15.99491 Da on Met (oxidation). A maximum of four modifications of any one type and five total modifications were allowed per peptide. Sequest XCorr and dCn¢ 18 score cutoffs were empirically determined for the entire data set, and mass deviation (in p.p.m.) and peptide solution charge filters were determined for each sample individually, using decoy matches as a guide 28 and aiming to maximize the number of peptide spectral matches, although maintaining an estimated FDR of r1%. Identified phosphopeptides passing our filtering criteria were submitted to the Ascore algorithm 29 for precise site localization. 
